AWAmy Y. Wang

Amy Y. Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amy Y. Wang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Min Gao

    Informatics Institute, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA

    2 shared publications
  • Xinyang Zhao

    Department of Biochemistry and Molecular Genetics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA

    2 shared publications
  • Yu Chen

    Department of Genetics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA

    2 shared publications
  • Zechen Chong

    Department of Biomedical Informatics and Data Science, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

    2 shared publications
  • Amy Chuang

    Southern California Clinical and Translational Institute, University of Southern California, Los Angeles, California, USA

    1 shared publication
  • Barbara Benoit

    Research Information Science and Computing, Partners HealthCare, Boston, Massachusetts, USA

    1 shared publication

Latest Publications

  • Open Access

    Deciphering the exact breakpoints of structural variations using long sequencing reads with DeBreak

    by Yu Chen, Amy Y. Wang, Courtney A. Barkley, Yixin Zhang, Xinyang Zhao, Min Gao, Mick D. Edmonds, Zechen Chong

    Long-read sequencing has demonstrated great potential for characterizing all types of structural variations (SVs). However, existing algorithms have insufficient sensitivity and precision. To address these limitations, we present DeBreak, a computational method for comprehensive and accurate SV discovery. Based on alignment results, DeBreak employs a density-based approach for clustering SV candidates together with a local de novo assembly approach for reconstructing long insertions. A partial order alignment algorithm ensures precise SV breakpoints with single base-pair resolution, and a k-means clustering method can report multi-allele SV events. DeBreak outperforms existing tools on both simulated and real long-read sequencing data from both PacBio and Nanopore platforms. An important application of DeBreak is analyzing cancer genomes for potentially tumor-driving SVs. DeBreak can also be used for supplementing whole-genome assembly-based SV discovery.


  • Open Access

    DeBreak: Deciphering the exact breakpoints of structural variations using long sequencing reads

    by Yu Chen, Amy Wang, Courtney Barkley, Xinyang Zhao, Min Gao, Micky Edmonds, Zechen Chong

    Long-read sequencing has demonstrated great potential for characterizing all types of structural variations (SVs). However, existing algorithms have insufficient sensitivity and precision. To address these limitations, we present DeBreak, a novel method for comprehensive and accurate SV discovery. Based on alignment results, DeBreak employs a density-based approach for clustering SV candidates together with a local de novo assembly approach for reconstructing long insertions. A partial order alignment algorithm ensures precise SV breakpoints with single base-pair resolution, and a k-means clustering method can report multi-allelic SV events. DeBreak outperforms existing tools on both simulated and real long-read sequencing data from both PacBio and Nanopore platforms. An important application of DeBreak is analyzing cancer genomes for potentially tumor-driving SVs. DeBreak also demonstrates excellent performance in supplementing whole-genome assembly methods.


  • Open Access

    Development of a Coronavirus Disease 2019 (COVID-19) Application Ontology for the Accrual to Clinical Trials (ACT) network

    by Shyam Visweswaran, Malarkodi J Samayamuthu, Michele Morris, Griffin M Weber, Douglas MacFadden, Philip Trevvett, Jeffrey G Klann, Vivian S Gainer, Barbara Benoit, Shawn N Murphy, et al.

    Clinical data networks that leverage large volumes of data in electronic health records (EHRs) are significant resources for research on coronavirus disease 2019 (COVID-19). Data harmonization is a key challenge in seamless use of multisite EHRs for COVID-19 research. We developed a COVID-19 application ontology in the national Accrual to Clinical Trials (ACT) network that enables harmonization of data elements that are critical to COVID-19 research. The ontology contains over 50 000 concepts in the domains of diagnosis, procedures, medications, and laboratory tests. In particular, it has computational phenotypes to characterize the course of illness and outcomes, derived terms, and harmonized value sets for severe acute respiratory syndrome coronavirus 2 laboratory tests. The ontology was deployed and validated on the ACT COVID-19 network that consists of 9 academic health centers with data on 14.5M patients. This ontology, which is freely available to the entire research community on GitHub at https://github.com/shyamvis/ACT-COVID-Ontology, will be useful for harmonizing EHRs for COVID-19 research beyond the ACT network.